Atrial Fibrillation
Conditions
Brief summary
To compare the number of patients with AF recurrence detected in a 24-h Holter monitoring with a 5-day record.
Interventions
DEVICEdevice e-patch Implantation
The ePatch device (Phillips) was used. This device is attached to the sternum, using a specific dressing adapted for the device itself. Manufacturer's recommendations for skin preparation and placement will be followed. The device will remain in place for 4-5 days, at which time the patient will be readmitted for data extraction and reading. The team of research nurses will analyze the data through the ePatch platform and later, the electrophysiologists will review the results and make a diagnosis.
Sponsors
Hospital Clinic of Barcelona
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Inclusion criteria
* Have undergone an AF ablation procedure at the Hospital Clínic and have a 12-month follow-up planned. * Having been previously assessed by the AF nurse. * Having signed the informed consent.
Exclusion criteria
* Extreme skin fragility at chest level * Allergy to latex or adhesive tape * No electrophysiology follow-up at the Clínic hospital. * Patients who are already included in other studies that may interfere with the expected results of this one. * Patients with cognitive impairment or disorientation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| AF recurrence | up to 5 days | Number of patients with AF recurrence detected in a cardio loop monitoring. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Burden of AF | up to 5 days | Burden of AF in the two groups (Day/Hours/minuts) |
| Number of patients with recurrent AF / atrial flutter / atrial tachycardia | up to 5 days | Number of patients with recurrent AF / atrial flutter / atrial tachycardia in two groups |
| Total time of noise | up to 5 days | Total time of noise in each group |
| Adverse effects | up to 5 days | skin injuries, losses, allergies, etc. |
| premature losses | up to 5 days | loss of connection of the device before 5 days |
| time to analyze | min:hours | time it takes to analyze and interpret the logs obtained, in minutes. |
| Total time analized | up to 5 days | Total time analized in each group |
Countries
Spain
Outcome results
None listed